Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Bénédicte Comet"'
Autor:
Alain Vergnenegre, Margaux Geier, Florian Guisier, Regine Lamy, Bénédicte Comet, Gwenaelle Le Garff, Pascal Do, Henri Janicot, Hugues Morel, Chantal Decroisette, Michel Andre, Lionel Falchero, Nicolas Paleiron, Isabelle Monnet, the GFPC Team
Publikováno v:
Cancer Medicine, Vol 9, Iss 2, Pp 432-439 (2020)
Abstract Background Immune checkpoint inhibitors (ICIs) have been approved as second‐line therapy for advanced non–small cell lung cancers (NSCLCs) progressing after platinum‐based chemotherapy. However, some patients' disease progressed rapidl
Externí odkaz:
https://doaj.org/article/f888be4cb547443ca22958a679b90330
Autor:
Jacques Le Treut, Catherine Dubos-Arvis, O. Bylicki, Alain Vergnenegre, Jacky Crequit, Marie Marcq, Gwenaelle Le Garff, Nicolas Paleiron, Victor Basse, Isabelle Monnet, Pascal Thomas, Gislaine Fraboulet, Bénédicte Comet, Anne Madroszyk, Jean-Bernard Auliac
Publikováno v:
Cancer Management and Research. 11:10821-10826
Background Antiangiogenic agents have improved the prognosis of non-squamous non-small-cell lung cancers (NSCLCs), even though all the patients are not eligible to receive them because of counterindications linked to the tumor's characteristics or co
Autor:
Hugues Morel, R. Lamy, Alain Vergnenegre, Gfpc Team, H. Janicot, Nicolas Paleiron, Isabelle Monnet, Michel Andre, Florian Guisier, Chantal Decroisette, Pascal Do, Bénédicte Comet, Lionel Falchero, Gwenaelle Le Garff, Margaux Geier
Publikováno v:
Cancer Medicine
Cancer Medicine, Vol 9, Iss 2, Pp 432-439 (2020)
Cancer Medicine, Vol 9, Iss 2, Pp 432-439 (2020)
Background Immune checkpoint inhibitors (ICIs) have been approved as second‐line therapy for advanced non–small cell lung cancers (NSCLCs) progressing after platinum‐based chemotherapy. However, some patients' disease progressed rapidly and som
Autor:
Bénédicte Comet, G. Le Garff, H. Janicot, Chantal Decroisette, Nicolas Paleiron, Lionel Falchero, R. Lamy, Pascal Do, Florian Guisier, Isabelle Monnet, A. Vergnenegre, M. André, H. Morel, Margaux Geier
Publikováno v:
Journal of Thoracic Oncology. 13:S539-S540
Autor:
Marie Marcq, Pascal Thomas, Jacky Crequit, A. Madroszyk, G. Fraboulet, V. Basse, J. Le Treut, Isabelle Monnet, A. Vergnenegre, G. Le Garff, Nicolas Paleiron, Catherine Dubos-Arvis, O. Bylicki, Bénédicte Comet, Jean-Bernard Auliac
Publikováno v:
Journal of Thoracic Oncology. 13:S828-S829
Publikováno v:
Bulletin du cancer. 98(12)
Recurrences or second primary head and neck cancers meant, for a long time, therapeutic dead ends. Surgery was the standard treatment, but could only be achieved in 25% of the patients. The GETTEC-GORTEC (99-01) randomized trial showed that radiochem
Publikováno v:
Soins; la revue de reference infirmiere. (733)